Restoration of cytoskeletal polarization and increased tumor infiltration were potential mechanisms of immune enhancement in vivo in TIL from tumors treated with the A2AR antagonist ZM 241385 together with anti-TIM3 mAb. The gene discussed is ADORA2A; the disease is neoplasm.